Blocking or inhibiting lipid metabolism-related proteins, such as peroxisome proliferator-activated receptors (PPARs), Sterol-regulatory element binding proteins (SREBPs), and FASN, can inhibit the proliferation and metastasis of bladder cancer cells 71, 72. Here, FASN is linked to urinary bladder carcinoma.